Canaccord Starts Pharming Group (PHAR) at Buy, PT $37 Apr 10, 2026 05:19AM
H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR): "well positioned to drive value" Mar 12, 2026 11:53AM
Pharming Group N.V. (PHAR) Tops Q3 EPS by 1c Nov 6, 2025 06:28AM
H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR) Oct 2, 2025 06:44AM
H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR) Jul 1, 2025 06:52AM


May 9, 2025 04:53PM Pharming Group N.V. (PHAR) Misses Q1 EPS by 1c
Apr 24, 2025 07:07AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Mar 14, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Dec 17, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Dec 12, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Dec 9, 2024 04:36AM Jefferies Starts Pharming Group (PHAR) at Buy
Oct 28, 2024 08:20AM Pharming Group (PHAR) PT Lowered to $30 at Oppenheimer
Oct 24, 2024 04:35AM Pharming Group N.V. (PHAR) Misses Q3 EPS by 0c ; Offers Guidance
Oct 15, 2024 06:33AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Oct 11, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Sep 27, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR)
Aug 1, 2024 08:35AM Pharming Group N.V. (PHAR) Reports In-Line Q2 EPS